MedAware

MedAware’s medication safety monitoring platform applies a personalized look at the appropriateness of a patient’s medication therapy at each stage of their treatment journey. This novel approach lives seamlessly within existing technology systems, EHRs, and devices—streamlining existing workflows, saving clinical time, and enabling timely patient intervention before harm occurs. MedAware’s AI-powered medication safety monitoring platform closes a critical, growing gap in US healthcare delivery by evaluating patient-specific risk of medication-related harm at every point of their hospital stay. This proprietary approach allows pharmacy teams to maintain the highest levels of patient care quality while gaining scalable operational efficiencies and standardizing best practices system-wide.           

“MedAware dramatically improves the quality of pharmacy-facing alerts,” said Trish Tanner, Chief Pharmacy Officer at Ballad Health. “Its accuracy significantly reduces alert fatigue, exponentially increasing the quality of actionable alerts for pharmacists. As a result, the software therefore also enables substantial savings in time and effort for pharmacists and providers."

MedAware was founded following a tragic event when a nine-year-old boy died simply because his physician accidentally selected the wrong drug by mistake when choosing which medication to order for the child from a medication selection list. This mistake was not due to bad judgment on the side of the physician, but rather simple human error - one that proved to be fatal. With the understanding that legacy medication decision support solutions failed to save this boy, a seasoned team of physician-scientists and machine learning experts established MedAware to ensure the highest level of safety for patients and their care teams.

When it comes to medicine, mistakes can be dangerous and costly. In the US:    

·      Medical errors are the fourth leading cause of death

·      7M preventable medication errors result in injury or death every year    

·      The total annual cost of medical liability claims in the US is estimated to be around $13B      

Transforming Patient Safety         

MedAware's AI-powered patient safety platform:

●    Mitigates the risk of Medication Errors

●     Prevents Evolving Adverse Drug Events      

●     Drives Medication List Continuity across Care Transitions

●     Reduces Polypharmacy risks

●     Drives Operational Efficiency

MedAware's Solution    

As MedAware grows its presence in the United States, it markets two modules to transform the practice of pharmacy. The first module, Assisted Order Verification, alleviates the pharmacist’s cognitive burden during the order review and verification process,     while enabling them to more confidently approve medication orders. The second module, Clinical Monitoring, proactively visualizes real-time evolving risk of medication related harm that is otherwise undetected, driving timely pharmacist-led interventions and improving patient outcomes.

Underpinning these modules, is a powerful platform incorporating AI, statistical and clinical methods to inform medication related risk.           

By continuously analyzing and harnessing prescription patterns across millions of patients around the globe, the software accurately flags medications that could put a patient at risk. Due to the high clinical relevancy of its medication alerts, providers and pharmacists have been shown to take clinical action significantly more often than with traditional systems alone. MedAware's alerts lead to prescription modifications 43% of the time, compared to only 5% for legacy system alerts. MedAware goes beyond traditional medication alert systems and drug-drug interaction knowledge bases. As no two patients or providers are alike, the company applies a level of specificity and scrutiny that takes into account the appropriateness of a medication for an individual patient and an individual prescriber. Compared to legacy systems that flag 15-25% of prescriptions with only 16% clinical relevance, MedAware’s platform alerts on just 3-5% of prescriptions, achieving 85% clinical relevance. This significantly reduces alert fatigue for healthcare providers while offering a more accurate patient health assessment.

 “Because it is not rule-based, MedAware represents a paradigm shift in medication related risk-mitigation and an innovative approach to improving patient safety,” says Dr. David Bates, Professor of Medicine at Harvard Medical School Said Bo Wilkes, Chief Growth Officer at Ballad Health and Ballad Ventures: “Innovation is the key to transforming how we provide care – especially in rural America – and we are excited about the partnership with MedAware and its very tangible potential to enhance care.”